ES546594A0 - Un procedimiento para preparar un anticuerpo monocional anti-urocinasa. - Google Patents

Un procedimiento para preparar un anticuerpo monocional anti-urocinasa.

Info

Publication number
ES546594A0
ES546594A0 ES546594A ES546594A ES546594A0 ES 546594 A0 ES546594 A0 ES 546594A0 ES 546594 A ES546594 A ES 546594A ES 546594 A ES546594 A ES 546594A ES 546594 A0 ES546594 A0 ES 546594A0
Authority
ES
Spain
Prior art keywords
urokinase
antibody
urocinase
monotional
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546594A
Other languages
English (en)
Other versions
ES8704351A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848422007A external-priority patent/GB8422007D0/en
Priority claimed from GB858508244A external-priority patent/GB8508244D0/en
Priority claimed from GB858510716A external-priority patent/GB8510716D0/en
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of ES8704351A1 publication Critical patent/ES8704351A1/es
Publication of ES546594A0 publication Critical patent/ES546594A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9723—Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES546594A 1984-08-31 1985-08-30 Un procedimiento para preparar un anticuerpo monocional anti-urocinasa. Expired ES8704351A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848422007A GB8422007D0 (en) 1984-08-31 1984-08-31 Anti-urokinase monoclonal antibody
GB858508244A GB8508244D0 (en) 1985-03-29 1985-03-29 Anti-urokinase monoclonal antibody
GB858510716A GB8510716D0 (en) 1985-04-26 1985-04-26 Anti-urokinase monoclonal antibody

Publications (2)

Publication Number Publication Date
ES8704351A1 ES8704351A1 (es) 1987-04-01
ES546594A0 true ES546594A0 (es) 1987-04-01

Family

ID=27262453

Family Applications (3)

Application Number Title Priority Date Filing Date
ES546594A Expired ES8704351A1 (es) 1984-08-31 1985-08-30 Un procedimiento para preparar un anticuerpo monocional anti-urocinasa.
ES552074A Expired ES8706445A1 (es) 1984-08-31 1986-02-17 Un metodo en emparedado de doble anticuerpo para detectar o ensayar un antigeno seleccionado de urocinasa humana y un precursor de la misma
ES552073A Expired ES8707563A1 (es) 1984-08-31 1986-02-17 Un procedimiento para purificar urocinasa

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES552074A Expired ES8706445A1 (es) 1984-08-31 1986-02-17 Un metodo en emparedado de doble anticuerpo para detectar o ensayar un antigeno seleccionado de urocinasa humana y un precursor de la misma
ES552073A Expired ES8707563A1 (es) 1984-08-31 1986-02-17 Un procedimiento para purificar urocinasa

Country Status (16)

Country Link
EP (1) EP0192675B1 (es)
KR (1) KR930002834B1 (es)
AT (1) ATE56617T1 (es)
AU (1) AU590216B2 (es)
CA (1) CA1297818C (es)
DE (1) DE3579808D1 (es)
DK (1) DK176986D0 (es)
ES (3) ES8704351A1 (es)
FI (1) FI86255C (es)
GR (1) GR852008B (es)
HU (1) HU203257B (es)
IL (1) IL76187A0 (es)
NO (1) NO172549C (es)
NZ (1) NZ213125A (es)
PT (1) PT81050B (es)
WO (1) WO1986001411A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8604851D0 (en) * 1986-02-27 1986-04-03 Lepetit Spa Immunosorbent-amidolytic method
EP0241907A3 (en) * 1986-04-14 1989-09-13 The General Hospital Corporation Heterobifunctional antibodies and method of use
AT388618B (de) * 1987-05-05 1989-08-10 Binder Bernd Dr Verfahren zur quantitativen bestimmung von funktion und antigener konzentration einer in einer biologischen fluessigkeit enthaltenen substanz
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790663A (en) * 1970-07-07 1974-02-05 Us Health Preparation of dry antiserum coated solid-phase for radioimmunoassay of antigens
EP0084344A3 (en) * 1982-01-14 1983-08-03 Asahi Kasei Kogyo Kabushiki Kaisha Anti-urokinase monoclonal antibodies and process for preparing the same
BE896253A (fr) * 1983-03-24 1983-07-18 Wallone Region Anticorps monoclonaux diriges contre l'urokinase humaine
WO1985000663A1 (en) * 1983-07-25 1985-02-14 Beckman Instruments, Inc. Immunometric assay using polyclonal and monoclonal antibodies and a kit for use therein

Also Published As

Publication number Publication date
DK176986A (da) 1986-04-17
FI86255B (fi) 1992-04-30
KR870700022A (ko) 1987-02-28
PT81050A (en) 1985-09-01
FI861715A (fi) 1986-04-24
CA1297818C (en) 1992-03-24
PT81050B (pt) 1987-10-20
ES8704351A1 (es) 1987-04-01
KR930002834B1 (ko) 1993-04-10
ATE56617T1 (de) 1990-10-15
EP0192675A1 (en) 1986-09-03
DK176986D0 (da) 1986-04-17
IL76187A0 (en) 1985-12-31
GR852008B (es) 1985-12-30
EP0192675B1 (en) 1990-09-19
HU203257B (en) 1991-06-28
FI86255C (fi) 1992-08-10
DE3579808D1 (de) 1990-10-25
NO861554L (no) 1986-04-18
ES8706445A1 (es) 1987-07-01
ES8707563A1 (es) 1987-08-01
HUT40574A (en) 1987-01-28
NO172549C (no) 1993-08-04
NO172549B (no) 1993-04-26
AU4773085A (en) 1986-03-24
NZ213125A (en) 1991-06-25
WO1986001411A1 (en) 1986-03-13
FI861715A0 (fi) 1986-04-24
ES552074A0 (es) 1987-07-01
AU590216B2 (en) 1989-11-02
ES552073A0 (es) 1987-08-01

Similar Documents

Publication Publication Date Title
GB2128630A (en) Method of affinity purification employing monoclonal antibodies
DK0432249T3 (da) Monoklonale antistoffer over for beta-kæden i leukocytadhæsionsreceptoren, fremgangsmåder til fremstilling af disse antistoffer og anvendelse heraf
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
FI964845A (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
DE69021953D1 (de) Enzymimmuntest für Antigene und dafür verwendbare feste Phase.
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
IL93207A0 (en) A monoclonal antibody which binds to factor betaxiia and shows no substantial binding to factor xii
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
ES546594A0 (es) Un procedimiento para preparar un anticuerpo monocional anti-urocinasa.
ATE40216T1 (de) Monoklonaler antikoerper.
FI862978A (fi) Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.
DK329789D0 (da) Monoklonalt antistof
DK134487D0 (da) Monoklonalt antistof med affinitet for humant interleukin-2
EP0084344A3 (en) Anti-urokinase monoclonal antibodies and process for preparing the same
DE3468324D1 (en) Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
AU573748B2 (en) Monoclonal antibody to cancer procoagulant and immunoassay
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401